HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin).

Abstract
E-ISA247 (voclosporin) is a cyclosporin A analogue that is in late-stage clinical development for the treatment of autoimmune diseases and the prevention of organ graft rejection. The X-ray crystal structures of E-ISA247 and its stereoisomer Z-ISA247 bound to cyclophilin A have been determined and their binding affinities were measured to be 15 and 61 nM, respectively, by fluorescence spectroscopy. The higher affinity of E-ISA247 can be explained by superior van der Waals contacts between its unique side chain and cyclophilin A. Comparison with the known ternary structure including calcineurin suggests that the higher immunosuppressive efficacy of E-ISA247 relative to cyclosporin A could be a consequence of structural changes in calcineurin induced by the modified E-ISA247 side chain.
AuthorsAndreas Kuglstatter, Francis Mueller, Eric Kusznir, Bernard Gsell, Martine Stihle, Ralf Thoma, Joerg Benz, Launa Aspeslet, Derrick Freitag, Michael Hennig
JournalActa crystallographica. Section D, Biological crystallography (Acta Crystallogr D Biol Crystallogr) Vol. 67 Issue Pt 2 Pg. 119-23 (Feb 2011) ISSN: 1399-0047 [Electronic] United States
PMID21245533 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • voclosporin
  • Cyclosporine
  • Cyclophilin A
Topics
  • Crystallography, X-Ray
  • Cyclophilin A (chemistry, metabolism)
  • Cyclosporine (chemistry, metabolism)
  • Humans
  • Immunosuppressive Agents (chemistry, metabolism)
  • Isomerism
  • Models, Molecular
  • Protein Binding
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: